Logo image
Clinical studies in CRS and HIPEC: Trials, tribulations, and future directions-A systematic review
Journal article   Open access   Peer reviewed

Clinical studies in CRS and HIPEC: Trials, tribulations, and future directions-A systematic review

William F Morano, Marian Khalili, Dennis S Chi, Wilbur B Bowne, Jesus Esquivel and Sarah S Long
Journal of surgical oncology, v 117(2)
Feb 2018
PMID: 29120491
url
https://europepmc.org/articles/pmc6692902View
Accepted (AM)Open Access (License Unspecified) Open

Abstract

Chemotherapy, Cancer, Regional Perfusion Clinical Trials as Topic Cytoreduction Surgical Procedures Humans Hyperthermia, Induced Meta-Analysis as Topic Peritoneal Neoplasms - therapy Prognosis Survival Rate
The field of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) has suffered from a lack of clinical trials to validate its expanding use. To evaluate published and ongoing clinical trials seeking to better define role of CRS/HIPEC in the treatment of peritoneal surface malignancies. Systematic review by PubMed search was performed using terms "Clinical trial," "intraperitoneal chemotherapy," and "HIPEC." ClinicalTrials.gov and EudraCT registries were searched for active clinical trials. Eligibility included CRS/HIPEC trials investigating adult patient populations from published clinical reports and/or trials currently accruing or at completion. Thirteen published trials and 57 active clinical trials were included for review. Published and ongoing U.S. and international clinical trials for CRS and HIPEC are defining important parameters that include improving patient selection, strategic sequences of treatment, cytoreductive strategies, chemotherapeutics, optimal hyperthermic temperature and timing, and toxicity profiles. Main barriers or limitations to trial development remain patient enrollment, trial design, and oncologic community collaboration. Overall progress is positive with increasing number of clinical trials throughout the world. Collaboration between surgeons and the wider oncologic community will be crucial to validate this important treatment strategy.

Metrics

12 Record Views
41 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#5 Gender Equality
#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Oncology
Surgery
Logo image